Persones / Equip Humà

Angel Montero Carcaboso

Buscador de publicacions

Publicacions

  • Bailleul Q, Navarin P, Arcicasa M, Bal-Mahieu C, Carcaboso AM, Le Bourhis X, Furlan A, Meignan S and Leblond P.

    Evofosfamide Is Effective against Pediatric Aggressive Glioma Cell Lines in Hypoxic Conditions and Potentiates the Effect of Cytotoxic Chemotherapy and Ionizing Radiations

    Cancers . 13(8): 1804. Nº de cites: 6

    [doi:10.3390/cancers13081804]

  • Bukchin A, Sanchez-Navarro M, Carrera A, Resa-Parés C, Castillo H, Balaguer-Lluna L, Teixidó M, Gene-Olaciregui N, Giralt E, Carcaboso AM and Sosnik A.

    Amphiphilic Polymeric Nanoparticles Modified with a Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma

    ACS Applied Nano Materials . 4(2): 1314-1329. Nº de cites: 13

    [doi:10.1021/acsanm.0c02888]

  • Domenici G, Eduardo R, Castillo H, Orive G, Carcaboso AM and Brito C.

    PDX-Derived Ewing's Sarcoma Cells Retain High Viability and Disease Phenotype in Alginate Encapsulated Spheroid Cultures

    Cancers . 13(4): 879. Nº de cites: 4

    [doi:10.3390/cancers13040879]

  • Thomas L, Smith N, Saunders D, Zalles M, Gulej R, Lerner M, Fung KM, Carcaboso AM and Towner RA.

    OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma

    JOURNAL OF TRANSLATIONAL MEDICINE . 18(1): 424-424. Nº de cites: 7

    [doi:10.1186/s12967-020-02593-5]

  • Balakrishnan I, Danis E, Pierce A, Madhavan K, Wang D, Dahl N, Sanford B, Birks DK, Davidson N, Metselaar DS, Meel MH, Lemma R, Donson A, Vijmasi T, Katagi H, Sola I, Fosmire S, Alimova I, Steiner J, Gilani A, Hulleman E, Serkova NJ, Hashizume R, Hawkins C, Carcaboso AM, Gupta N, Monje M, Jabado N, Jones K, Foreman N, Green A, Vibhakar R and Venkataraman S.

    Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG

    CELL REPORTS . 33(3): 108286-108286. Nº de cites: 34

    [doi:10.1016/j.celrep.2020.108286]

  • Martinez-Lage M, Torres-Ruiz R, Puig-Serra P, Moreno-Gaona P, Martin MC, Moya FJ, Quintana-Bustamante O, Garcia-Silva S, Carcaboso AM, Petazzi P, Bueno C, Mora J, Peinado H, Segovia JC, Menendez P and Rodriguez-Perales S.

    In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells

    NATURE COMMUNICATIONS . 11(1): 5060-5060. Nº de cites: 54

    [doi:10.1038/s41467-020-18875-x]

  • Sánchez-Molina S, Figuerola-Bou E, Blanco ME, Sanchez-Jimenez M, Táboas-Outón P, Gomez-Gonzalez S, Ballaré C, García-Domínguez DJ, Prada-Varela E, Hontecillas-Prieto L, Carcaboso AM, Tirado ÓM, Hernandez-Muñoz MI, de Álava E, Lavarino C, Di Croce L and Mora J.

    RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis

    Science Advances . 6(43): 3058. Nº de cites: 24

    [doi:10.1126/sciadv.aba3058]

  • Bukchin, A, Sanchez-Navarro, M, Carrera, A, Teixido, M, Carcaboso AM, Giralt, E and Sosnik, A.

    Amphiphilic Polymeric Nanoparticles Modified with a Retro-Enantio Peptide Shuttle Target the Brain of Mice

    CHEMISTRY OF MATERIALS . 32(18): 7679-7693. Nº de cites: 15

    [doi:10.1021/acs.chemmater.0c01696]

  • Wiese M, Hamdan FH, Kubiak K, Diederichs C, Gielen GH, Nussbaumer G, Carcaboso AM, Hulleman E, Johnsen SA and Kramm CM.

    Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells

    CELL DEATH & DISEASE . 11(8): 673-673. Nº de cites: 36

    [doi:10.1038/s41419-020-02800-7]

  • Castillo H, Monterrubio C, Pascual-Pastó G, Gomez-Gonzalez S, Garcia-Dominguez DJ, Hontecillas-Prieto L, Resa-Parés C, Burgeño-Sandoval V, Paco-Mercader S, Gene-Olaciregui N, Vilà-Ubach M, Restrepo-Perdomo C, Cuadrado-Vilanova M, Balaguer-Lluna L, Pérez-Jaume S, Castañeda-Heredia A, Santa-María López V, Roldan-Molina M, Suñol M, de Alava E, Mora J, Lavarino C and Carcaboso AM.

    Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution

    JOURNAL OF CONTROLLED RELEASE . 324: 440-449. Nº de cites: 6

    [doi:10.1016/j.jconrel.2020.05.032]